Abstract
Hyperprolactinemia is commonly encountered with risperidone or paliperidone and may lead to sexual dysfunction, amenorrhea, and galactorrhea. We examined changes in prolactin and reported sexual functioning in patients switching from paliperidone palmitate (PP) or risperidone long-acting injectable (RLAI) to aripiprazole lauroxil (AL).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.